Co-Diagnostics, Inc. ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the ...
Analyze the bullish trends and strategies for Nifty and Nifty Bank futures amid key support levels for potential rebounds.
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
EFS Plastics calls for stronger policies and collaboration to boost post-consumer resin adoption amid low virgin plastic ...
Ampacet's AI system automatically corrects color variations in real time, improving quality and reducing waste in operations.
Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.
China NMPA grants marketing approval for Innovent Biologics' Tyvyt, a CTLA-4 monoclonal antibody: San Francisco Saturday, December 27, 2025, 16:00 Hrs [IST] Innovent Biologics Inc ...
Science moves forward on data. We all know this. But bad data leads science down dead ends. It wastes time. It wastes money.
TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite ...
Human immunodeficiency virus (HIV) infections are still fairly common and an estimated 40 million people worldwide are ...
Market expert Raja Venkatraman shares his top three stock picks to buy today, 24 December. Discover his exclusive picks and ...
TipRanks on MSN
Innovent wins landmark China approval for first domestic CTLA-4 neoadjuvant colon cancer therapy
Innovent Biologics ( ($HK:1801) ) has provided an update. Innovent Biologics announced that China’s National Medical Products Administration has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback